Molecular analysis of mutations in mutator colorectal carcinoma cell lines - PubMed (original) (raw)
. 1995 Nov;4(11):2057-64.
doi: 10.1093/hmg/4.11.2057.
Affiliations
- PMID: 8589681
- DOI: 10.1093/hmg/4.11.2057
Molecular analysis of mutations in mutator colorectal carcinoma cell lines
N P Bhattacharyya et al. Hum Mol Genet. 1995 Nov.
Abstract
The nature of mutations occurring in two colorectal carcinoma cell lines deficient in mismatch repair and displaying mutator phenotypes was determined. One of the lines (HCT116) exhibited a higher level of microsatellite instability than the second (DLD-1), although the rate of mutation at the selectable locus encoding the purine salvage enzyme hypoxanthine guanine phosphoribosyl transferase (HPRT) was equally elevated (about 350-450-fold relative to mismatch repair proficient cell lines). Transitions were the major class of mutations in the two mutator lines. In DLD-1 these mutations recurred at several sites that appeared to be hotspots. Frameshifts at a run of six guanine residues in the coding sequence for HPRT constituted 35% of mutations in HCT116. These frameshifts were highly unstable and reverted to wild type at high frequency. Larger deletions were also detected in HCT116. Although these deletions constituted a small proportion of mutations compared with the other types, our data suggest that the rate of deletion is elevated relative to mismatch repair proficient (hMLH1+) cell lines. These observations suggest that the gene(s) altered in DLD-1 may preferentially affect the repair of base mismatches while the alteration(s) in HCT116 may affect the repair of both mismatches and frameshifts.
Similar articles
- Spectra of spontaneous mutations at the hprt locus in colorectal carcinoma cell lines defective in mismatch repair.
Ohzeki S, Tachibana A, Tatsumi K, Kato T. Ohzeki S, et al. Carcinogenesis. 1997 Jun;18(6):1127-33. doi: 10.1093/carcin/18.6.1127. Carcinogenesis. 1997. PMID: 9214593 - Differences in the spectrum of spontaneous mutations in the hprt gene between tumor cells of the microsatellite mutator phenotype.
Malkhosyan S, McCarty A, Sawai H, Perucho M. Malkhosyan S, et al. Mutat Res. 1996 May;316(5-6):249-59. doi: 10.1016/s0921-8734(96)90007-7. Mutat Res. 1996. PMID: 8649458 - Mutator phenotypes in human colorectal carcinoma cell lines.
Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M. Bhattacharyya NP, et al. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6319-23. doi: 10.1073/pnas.91.14.6319. Proc Natl Acad Sci U S A. 1994. PMID: 8022779 Free PMC article. - DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines.
Branch P, Hampson R, Karran P. Branch P, et al. Cancer Res. 1995 Jun 1;55(11):2304-9. Cancer Res. 1995. PMID: 7757980 - The natural somatic mutation frequency and human carcinogenesis.
Simpson AJ. Simpson AJ. Adv Cancer Res. 1997;71:209-40. doi: 10.1016/s0065-230x(08)60100-1. Adv Cancer Res. 1997. PMID: 9111867 Review.
Cited by
- Explosive mutation accumulation triggered by heterozygous human Pol ε proofreading-deficiency is driven by suppression of mismatch repair.
Hodel KP, de Borja R, Henninger EE, Campbell BB, Ungerleider N, Light N, Wu T, LeCompte KG, Goksenin AY, Bunnell BA, Tabori U, Shlien A, Pursell ZF. Hodel KP, et al. Elife. 2018 Feb 28;7:e32692. doi: 10.7554/eLife.32692. Elife. 2018. PMID: 29488881 Free PMC article. - Human Pol ε-dependent replication errors and the influence of mismatch repair on their correction.
Agbor AA, Göksenin AY, LeCompte KG, Hans SH, Pursell ZF. Agbor AA, et al. DNA Repair (Amst). 2013 Nov;12(11):954-63. doi: 10.1016/j.dnarep.2013.08.012. Epub 2013 Sep 17. DNA Repair (Amst). 2013. PMID: 24051051 Free PMC article. - The lower bound to the evolution of mutation rates.
Lynch M. Lynch M. Genome Biol Evol. 2011;3:1107-18. doi: 10.1093/gbe/evr066. Epub 2011 Aug 4. Genome Biol Evol. 2011. PMID: 21821597 Free PMC article. - The mutator phenotype in cancer: molecular mechanisms and targeting strategies.
Prindle MJ, Fox EJ, Loeb LA. Prindle MJ, et al. Curr Drug Targets. 2010 Oct;11(10):1296-303. doi: 10.2174/1389450111007011296. Curr Drug Targets. 2010. PMID: 20840072 Free PMC article. Review. - MutSbeta exceeds MutSalpha in dinucleotide loop repair.
Kantelinen J, Kansikas M, Korhonen MK, Ollila S, Heinimann K, Kariola R, Nyström M. Kantelinen J, et al. Br J Cancer. 2010 Mar 16;102(6):1068-73. doi: 10.1038/sj.bjc.6605531. Epub 2010 Feb 16. Br J Cancer. 2010. PMID: 20160730 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous